Mirova Regeneron Pharmaceuticals, Inc. Transaction History

Mirova

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$775.18 - $881.7 $8,526 - $9,698	-11 Reduced 4.74%	221 $194,000
Q3 2023 Nov 14, 2023	SELL	$692.45 - $844.37 $253,436 - $309,039	-366 Reduced 61.2%	232 $190,000
Q2 2023 Aug 11, 2023	SELL	$700.03 - $830.35 $436,118 - $517,308	-623 Reduced 51.02%	598 $429,000
Q1 2023 May 12, 2023	BUY	$680.49 - $826.97 $451,164 - $548,281	663 Added 118.82%	1,221 $1 Million
Q4 2022 Feb 13, 2023	SELL	$705.89 - $766.39 $411,533 - $446,805	-583 Reduced 51.1%	558 $402,000
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $367,340 - $463,564	-640 Reduced 35.93%	1,141 $786,000
Q2 2022 Aug 12, 2022	BUY	$548.35 - $738.84 $605,378 - $815,679	1,104 Added 163.07%	1,781 $1.05 Million
Q1 2022 May 13, 2022	SELL	$595.12 - $698.43 $6,546 - $7,682	-11 Reduced 1.6%	677 $472,000
Q4 2021 Feb 14, 2022	SELL	$543.48 - $670.97 $619,567 - $764,905	-1,140 Reduced 62.36%	688 $434,000
Q3 2021 Nov 12, 2021	BUY	$574.03 - $680.96 $95,288 - $113,039	166 Added 9.99%	1,828 $1.11 Million
Q2 2021 Aug 13, 2021	BUY	$472.8 - $558.54 $47,280 - $55,854	100 Added 6.4%	1,662 $928,000
Q1 2021 May 14, 2021	BUY	$446.73 - $548.2 $96,493 - $118,411	216 Added 16.05%	1,562 $739,000
Q4 2020 Feb 12, 2021	BUY	$478.3 - $607.98 $612,702 - $778,822	1,281 Added 1970.77%	1,346 $650,000
Q3 2020 Nov 12, 2020	BUY	$544.75 - $658.21 $35,408 - $42,783	65 New	65 $36,000

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Mirova, based on Form 13F filings with the SEC.

Stay updated on Mirova with notifications on news.